We recently identified the FOXO4 p53 axis as pivotal in maintaining the viability of senescent cells, and that senescent cells can be targeted selectively with the senolytic peptide FOXO4-DRI
Lyophilized (freeze-dried) BPC-157 powder remains stable for extended periods when kept refrigerated or frozen
Choosing the right pharmacological treatment in these patients remains challenging due to the heterogeneous patient population, patients expectation of the treatment outcome, unavailability of efficacious drugs, and the multifactorial and incompletely understood underlying pathophysiology
Symptoms like dark-colored urine, dry mouth, headache, and dizziness will show dehydration
Researchers combining retatrutide with recovery peptides should be especially attentive to nutritional adequacy and may benefit from stacking protocols that account for timing and injection scheduling
Eaton S, Fukumoto K, Stefanutti G, Spitz L, Zammit VA, Pierro A: Myocardial carnitine palmitoyltransferase I as a target for oxidative modification in inflammation and sepsis
